
    
      All patients will receive incision and drainage and wound cultures. Patients will then be
      randomized to 1) septa double strength two pills orally twice a day x 7 days or 2)placebo.
      Patients will then return to the emergency room on days 3 and 7 for wound repacking and
      evaluation. The primary outcome recurrence rates within 30 days of treatment. Patients who
      are not improving at the following visit will then be treated with additional antibiotics if
      needed. Data will be analyzed both by initial randomization and intention to treat.
    
  